The study proves for the first time that miR-630 is upregulated in a majority of ccRCC patients. It also shows that miR-630 expression is an independent prognostic factor for patients with renal cancer, which might be a potential valuable biomarker for ccRCC.
13
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Lorenzo Galluzzi, Eugenia Morselli, Ilio Vitale et al. · Cancer Research · 2010 · 280 citations · Full text
Santosh K. Patnaik, Eric Kannisto, Steen Knudsen et al. · Cancer Research · 2009 · 250 citations · Full text
Martin Spahn, Susanne Kneitz, Claus Jürgen Scholz et al. · International Journal of Cancer · 2009 · 227 citations · Full text
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
David Juan, Gabriela Alexe, Travis J. Antes et al. · Urology · 2009 · 224 citations